Tuesday, July 28, 2026

Inventage Lab to present mRNA-LNP large-scale manufacturing platform at CRS 2026

Inventage Lab showcases its IVL-GeneFluidic® platform for mRNA lipid nanoparticles at CRS 2026, enhancing local manufacturing capabilities.

Unlocking Efficiency: How Capora’s AI-Driven TMS and WMS Transform Logistics in 2026

UMOS ONE unveils Capora, an AI-driven logistics service, at KOREA MAT 2026, enhancing efficiency in transportation and warehousing.

National Assembly speaker tells U.S. Republicans to “refrain from interference” over Coupang issue

National Assembly Speaker Woo Won-shik criticized U.S. lawmakers for interfering in Korea's affairs regarding Coupang's regulations.

Tag: ALT-B4

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.